Patents for C12R 1 - Micro-organisms (92,025)
11/2000
11/09/2000WO2000066763A1 Methods, compositions and kits for biological indicator of sterilization
11/09/2000WO2000066760A1 Method for producing l-phosphinothricine by enzymatic transamination with aspartate
11/09/2000WO2000066759A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/09/2000WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000WO2000066738A1 Process for producing recombinant insulin from novel fused protein
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066711A2 Streptococcus gordonii strains resistant to fluorodeoxyuridine
11/09/2000WO2000066710A2 Method for the preservation of viruses and mycoplasma
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000042195B1 Schizochytrium pks genes
11/09/2000WO2000039276A3 Microbial transformation method for the preparation of an epothilone
11/09/2000WO2000037658A3 Chemically modified enzymes with multiple charged variants
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/09/2000WO2000034454A3 Microcellular polymers as cell growth media and novel polymers
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000031236A3 Vectors for gene mutagenesis and gene discovery by gene trapping
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000026355A3 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism
11/09/2000WO2000015826A3 Leptin induced genes
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000CA2372221A1 Methods for producing recombinant insulin from novel fusion proteins
11/09/2000CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000CA2371577A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370798A1 Streptococcus gordonii strains resistant to fluorodeoxyuridine
11/09/2000CA2369830A1 Methods, compositions and kits for biological indicator of sterilization
11/09/2000CA2365277A1 Method for the preservation of viruses and mycoplasma
11/08/2000EP1050582A2 Recombinant microorganisms expressing small rubber particle-associated protein
11/08/2000EP1049794A1 Method for producing l-carnitine from crotonobetaine
11/08/2000EP1049790A1 Process for making desired polypeptides in yeast
11/08/2000EP1049789A1 An autoregulatory system for validating microbial genes as possible antimicrobial targets using a tetracycline-controllable element
11/08/2000EP1049784A1 POLYHYDROCYALKANOATE BIOSYNTHESIS-RELATED GENES DERIVED FROM $i(ALCALIGENES LATUS)
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049713A2 Antifreeze protein
11/08/2000EP1049707A1 Ustilipides, method for the production and the use thereof
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000EP0635132B1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/08/2000CN1272881A Protease variants and compositions
11/08/2000CN1272877A Feed product
11/08/2000CN1272791A Pharmaceutical preparation comprising lactobacillus casei phamnosus
11/08/2000CN1058294C Method for preparation of compound named 'Leustroducsins'
11/07/2000US6143950 Plant steroid 5α reductase, DET2
11/07/2000US6143949 Method for transferring gene
11/07/2000US6143878 Sox-9 gene and protein and use in the regeneration of bone or cartilage
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143865 Amino acid sequences which are reactive with viral antibodies; for accurate and sensitive immunoassay diagnosis
11/07/2000US6143708 α-amylase mutants
11/07/2000US6143554 Process for producing optically active n-substituted azetidine-2 carboxylic acid compound
11/07/2000US6143552 Escherichia coli which produces l-amino acid but cannot grow in synthetic media containing that amino acid as sole nitrogen source in amount of 5 mg/ml or below; accumulation of product in culture medium; foods; feeds; drugs
11/07/2000US6143550 Bacillus thuringiensis strains and their insecticidal proteins
11/07/2000US6143546 Nucleotide sequence that codes a proteolytic enzyme; for preparing bread products; for producing proteins and/or protein hydrosylates that give foods favorable flavors
11/07/2000US6143539 UDP-glucose pyro phosphorylase enzymes from nonparasitic protozoa
11/07/2000US6143536 DNA encoding a thermostable DNA polymerase
11/07/2000US6143530 Circular DNA expression cassettes for in vivo gene transfer
11/07/2000US6143525 Phage inducible expression vector; for prevention of viral infections during dairy and food processing
11/07/2000US6143518 Expression vectors comprising nucleotide sequences which for code heterologous polypeptides which can be expressed in bacteria
11/07/2000US6143297 Immunizing a mammals; forming antibodies
11/07/2000US6143295 Low molecular weight protein
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/07/2000CA2218875C Improvements in the in situ pcr
11/07/2000CA2075711C Vaccine and method therefor
11/02/2000WO2000065087A1 Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity
11/02/2000WO2000065070A2 Cell culture process for glycoproteins
11/02/2000WO2000065058A1 Method for down-regulating il5 activity
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
11/02/2000WO2000026417A9 Detection of negative-strand rna viruses
11/02/2000WO2000026349A9 Recombinant oleandolide polyketide synthase
11/02/2000WO2000018932A3 Receptor based antagonists and methods of making and using
11/02/2000WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
11/02/2000EP1048738A1 A process for the preparation of phosphatidylserines
11/02/2000EP1048736A1 DNA-construct for the tissue specific expression of a blood coagulation factor
11/02/2000EP1048735A1 DNA-construct for the tissue-specific expression of a blood coagulation factor
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048731A2 Method for cloning and producing the SwaI restriction endonuclease
11/02/2000EP1048215A1 Enhanced growth of lactic acid bacteria in milk
11/02/2000EP1047789A2 Process for the production of alanine by recombinant microorganisms
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19919848A1 Verfahren zur Herstellung von L-Phosphinothricin durch enzymatische Transaminierung mit Aspartat A process for preparing L-phosphinothricin by enzymatic transamination with aspartate
11/02/2000CA2370469A1 Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity
11/02/2000CA2370467A1 Gluconobacter suboxydans sorbitol dehydrogenase, genes and methods of use thereof
11/02/2000CA2370391A1 Method for down-regulating il5 activity
11/01/2000CN1272138A Protease variants and compositions
11/01/2000CN1058055C L-ascorbic acid production in microorganisms and its permented culture
11/01/2000CN1058020C Angiotensin converting enzyme inhibitor and method for preparing same
10/2000
10/31/2000US6140486 Isolated nucleic acid having a defined nucleotide sequence from vibrio marinus; for production docosahexanoic acid in transgenic plants; nutrients; dietetics
10/31/2000US6140468 Obtained by recombinant dna technology using baculovirus expression system; has defined n-terminal amino acid sequence; does not complex with alpha-1-antichymotrypsin or alpha-2-macroglobulin; does not degrade specific substrates
10/31/2000US6140118 Avian blastodermal cell lines
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140104 Nucleic acids which code for an insecticidal protein agains beetles; pesticides; biological pest control
10/31/2000US6140103 Regulated protein expression in stably transfected mammalian cells
10/31/2000US6140100 Cell-targeting molecule comprising a mutant human carboxypeptidase A
10/31/2000US6140095 Alkalitolerant xylanases
10/31/2000US6140088 With an amino acid dehydrogenase in the presence of ammonia and a co-factor
10/31/2000US6140078 Derivable from a lactic acid bacterium in isolation from the coding sequence normally controlled by said promoter in a wild-type lactic acid bacterium
10/31/2000US6140073 Useful in the promotion of tissue repair